On December 31, 2009, Regeneron Pharmaceuticals (REGN) had a market capitalization of $2B, based on 81.17M shares at a price of $24.08.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2009 | $24.08 | 12,849,200 | 81,169,000 | $1,954,289,779.20 |
November 2009 | $18.27 | 14,868,300 | 81,169,000 | $1,483,095,617.30 |
October 2009 | $15.63 | 12,352,000 | 81,169,000 | $1,268,914,977.00 |
September 2009 | $19.22 | 9,831,000 | 79,866,000 | $1,534,832,841.60 |
August 2009 | $22.63 | 8,797,700 | 79,866,000 | $1,807,607,178.00 |
July 2009 | $21.39 | 10,370,700 | 79,866,000 | $1,708,197,967.80 |
June 2009 | $17.84 | 12,010,700 | 79,626,000 | $1,420,806,531.00 |
May 2009 | $15.20 | 11,631,800 | 79,626,000 | $1,210,697,404.80 |
April 2009 | $13.20 | 11,648,300 | 79,626,000 | $1,051,333,928.40 |
March 2009 | $13.80 | 13,003,400 | 79,498,000 | $1,097,135,998.40 |
February 2009 | $14.19 | 9,266,500 | 79,498,000 | $1,128,013,021.60 |
January 2009 | $17.41 | 6,654,700 | 79,498,000 | $1,383,694,489.20 |
December 2008 | $18.28 | 9,741,000 | 79,498,000 | $1,453,350,636.80 |
November 2008 | $15.39 | 9,644,600 | 79,498,000 | $1,223,792,212.00 |
October 2008 | $19.22 | 14,289,100 | 79,498,000 | $1,527,760,764.80 |
September 2008 | $21.74 | 16,925,000 | 78,937,000 | $1,715,837,781.60 |
August 2008 | $21.63 | 12,932,400 | 78,937,000 | $1,707,194,180.10 |
July 2008 | $21.80 | 13,991,200 | 78,937,000 | $1,720,558,214.20 |
June 2008 | $14.38 | 17,958,600 | 78,689,000 | $1,131,421,917.60 |
May 2008 | $19.82 | 13,500,400 | 78,689,000 | $1,559,230,403.90 |
April 2008 | $19.54 | 9,983,300 | 78,689,000 | $1,537,284,041.80 |
March 2008 | $19.11 | 16,952,800 | 78,493,000 | $1,499,852,093.30 |
February 2008 | $19.69 | 11,527,800 | 78,493,000 | $1,545,181,800.80 |
January 2008 | $20.19 | 13,352,500 | 78,493,000 | $1,585,040,546.20 |
December 2007 | $24.05 | 12,706,300 | 78,493,000 | $1,887,513,321.70 |
